VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 34 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,329,807 | -12.9% | 209,505 | 0.0% | 1.15% | -45.6% |
| Q4 2022 | $6,119,641 | +42.4% | 209,505 | 0.0% | 2.11% | +36.4% |
| Q3 2022 | $4,297,000 | +77.3% | 209,505 | 0.0% | 1.55% | +102.4% |
| Q2 2022 | $2,424,000 | -37.4% | 209,505 | 0.0% | 0.76% | -8.3% |
| Q1 2022 | $3,874,000 | -6.5% | 209,505 | 0.0% | 0.83% | +44.8% |
| Q4 2021 | $4,142,000 | +20.2% | 209,505 | 0.0% | 0.58% | +41.2% |
| Q3 2021 | $3,446,000 | -10.1% | 209,505 | 0.0% | 0.41% | +2.5% |
| Q2 2021 | $3,832,000 | +9.5% | 209,505 | 0.0% | 0.40% | -38.4% |
| Q1 2021 | $3,501,000 | +1.6% | 209,505 | 0.0% | 0.65% | -16.4% |
| Q4 2020 | $3,446,000 | – | 209,505 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,696,340 | $55,302,000 | 8.89% |
| TCG Crossover Management, LLC | 1,164,000 | $23,874,000 | 7.16% |
| VR Adviser, LLC | 2,130,308 | $43,693,000 | 6.74% |
| Fairmount Funds Management LLC | 1,369,623 | $28,091,000 | 4.94% |
| Paradigm Biocapital Advisors LP | 1,636,211 | $33,559,000 | 4.47% |
| Kynam Capital Management, LP | 1,000,000 | $20,510,000 | 4.32% |
| Vivo Capital, LLC | 1,660,019 | $34,047,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 362,735 | $7,440,000 | 3.20% |
| Ghost Tree Capital, LLC | 535,000 | $10,973,000 | 3.08% |
| Logos Global Management LP | 1,000,000 | $20,510,000 | 2.52% |